Farms.com Home   News

Mixed fortunes for U.S. corn yields in 2024

Aug 01, 2024
By Farms.com

Silking stage reached, but crop quality varies widely

 

The U.S. corn crop is experiencing wide variability in its growth and development, as reported by the USDA’s Crop Progress Report.

More than 60% of the corn in the nation's top 18 corn-producing states has reached the silking stage. Yet, the overall crop quality is inconsistent, with only 16% rated excellent and over 30% falling between fair and very poor.

Kentucky illustrates these contrasts vividly. Chad Lee from the University of Kentucky reports excellent conditions in the western part of the state, predicting a strong harvest. Conversely, eastern areas face drought stress that jeopardizes crop yields and could necessitate insurance claims.

This pattern of variability is mirrored nationwide, with some regions enjoying optimal conditions for growth, while others face adversities such as drought and flooding. These challenges highlight the importance of advanced farming techniques and technologies that enhance crop durability and water efficiency.

With the harvest approaching, the agricultural sector is closely monitoring how these diverse conditions will translate into final yields.

This year’s crop variability highlights the ongoing need for research and innovations that enhance the resilience of the U.S. agricultural landscape and safeguard food security.


Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.